Success Stories: Thanks to Premium Processing Upgrade, NIW Approval Won in Just 7 Days for a Process Development Scientist from India Working in Biotechnologies

 

Client’s Testimonial:

“Thanks so much for your efforts with my petition.”


On February 7th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Process Development Scientist in the Field of Biotechnologies (Approval Notice).


General Field: Biotechnologies

Position at the Time of Case Filing: Process Development Scientist

Country of Origin: India

State of Residence at the Time of Filing: California

Approval Notice Date: February 7th, 2023

Processing Time: 7 days (Premium Processing Requested)


Case Summary:

A National Interest Waiver (NIW) case requires the applicant to prove beyond reasonable doubt that they and their work in the chosen area of study are inherently beneficial for the U.S.A. This is what we assist our clients do, by helping them write their petitions to the USCIS.

So when an Indian process development scientist in biotechnologies came to us for her NIW case, we had to make sure that as an expert in the field of biotechnologies her work was of benefit to the U.S. This was made possible by using the following data collected from her documents:

  • Her proposed endeavor is to continue her research on utilizing downstream separation, product extraction, and recovery techniques in order to develop scalable and cost-effective purification schemes for the large-scale production of valuable compounds for various applications, including bio-therapeutic drugs.
  • Her research advancing her proposed endeavor is of great importance because it hastens important global industries’ transition to a green production model. She is conducting research that simultaneously improves these industries’ environmental footprint and bottom line.
  • Her research also has major implications for the United States. In developing cost-effective and scalable extraction and purification schemes, she enables the large-scale implementation of biotechnologies in critical industries including agriculture, healthcare, and food.
  • Due to its clear national importance, her research has in fact been supported with funding from the National Science Foundation.
  • She has also completed at least 2 reviews to date and her research has resulted in 5 peer-reviewed journal articles (three of them first-authored) and 2 editor-reviewed papers (both first-authored).
  • These publications have been cited a total of 88 times according to Google Scholar, thereby demonstrating that these publications are widely recognized and relied upon in the field of biotechnologies.
  • Not only this, but she has also pursued research directly related to her proposed endeavor of developing scalable and cost-effective purification schemes to enable the large-scale production of valuable compounds for various applications for 8 years.
  • Along with this, she has obtained 4 letters of recognition from other well-known experts in the field, two of whom said:
“Her contributions to the field have enabled the manufacturing of products that improve the health and well-being of countless individuals across the world and facilitate the transition from carbon-emission heavy fossil fuels to renewable, eco-friendly energy sources. Her ongoing work as a scientist at Avid Bioservices, a biopharmaceutical development and manufacturing company in the United States, finds her continuing to develop scalable purification schemes for obtaining valuable biological products for use in pharmaceuticals.”

“[The client’s] development of a streamlined process to extract resources from microalgae has applications in improving the production of plant-based food, helping sustain and propel the rapid growth of this billion-dollar industry in the United States and across the world.”

So when her approval came through, we were very happy to have helped her. We wish her success in her future endeavors.